All Sauce from Weekly Sauce:

The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer’s drug Leqembi, clearing the way for insurance coverage of the pricey drug. “The full FDA approval will open the floodgates for people with early Alzheimer’s to get this drug. It’s a big deal because it’s very expensive at $26,500 per year,”…  read on >  read on >

Record-breaking heat waves are pummeling the United States and the world, causing many to wonder how much of this a body can take and still survive. The limit is somewhere between 104 and 122 degrees Fahrenheit if you’re sitting perfectly still, according to a small study conducted in the United Kingdom. Researchers say they are…  read on >  read on >

Could swings in your blood fat levels increase your chances of being diagnosed with Alzheimer’s disease? Yes, suggests a new study that found fluctuating cholesterol levels among older adults may increase the risk for Alzheimer’s disease and other dementias. Those who had the most fluctuations in cholesterol had a 19% higher risk of developing Alzheimer’s…  read on >  read on >

Did you know the U.S. Centers for Disease Control and Prevention estimates that there were nearly 68,000 new cases of acute hepatitis C in 2020 and over 107,000 newly reported cases of chronic hepatitis C? To help you better understand how to manage this viral infection of the liver, here, experts reveal the most common…  read on >  read on >